Competitive enzyme-linked immunoassay of monoclonal immunoglobulin G anti-D preparations

Transfusion Medicine

Volumn 13, Issue 3, 2003, Pages 153-160

  Thorpe, Susan J ^a   Fox, B ^a   Turner, C ^a   Scott, M ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Anti D; Competitive enzyme linked immunoassay; Potency; Specific activity

Indexed keywords

BIOTINYLATED MONOCLONAL RHESUS D ANTIBODY 5; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; RHESUS D ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; DOSE RESPONSE; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNODIFFUSION; NEWBORN HEMOLYTIC DISEASE; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SUPERNATANT;

EID: 0038317906     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.2003.00436.x     Document Type: Article

References (14)

1. Anonymous (2001) Assay of human anti-D immunoglobulin 2.7.13. Pharmeuropa, 13, 772-774.
2. Bangham, D.R., Kirkwood, T.B., Wybrow, G., Hughes-Jones, N.C. & Gunson, H.H. (1978) International collaborative study of assay of anti-D (anti-Rh) immunoglobulin. British Journal of Haematology, 38, 407-423.
3. Finney, D.J. (1978) Statistical methods in biological assay, 3rd edition. Griffin, London.
4. Goodrick, J., Kumpel, B., Pamphilon, D., Fraser, I., Chapman, G., Dawes, B. & Anstee, D. (1994) Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers. Clinical and Experimental Immunology, 98, 17-20.
5. Gunson, H.H., Bowell, P.J. & Kirkwood, T.B. (1980) Collaborative study to recalibrate the International Reference Preparation of anti-D immunoglobulin. Journal of Clinical Pathology, 33, 249-253.
6. - volunteers. Blood, 86, 1701-1709.
7. Kumpel, B.M. & Jackson, D.J. (2001) Quantitation of IgG anti-D bound to red cells of normal and weak D phenotype by flow cytometry and IAGT, using a high sensitivity sensitisation protocol and recommended workshop protocols. Testers' Report, 4th International Workshop (available from: http://www.ints.fr/4thworkshop/netscap/index.htm).
8. Liu, W., Avent, N.D., Jones, J.W., Scott, M.L. & Voak, D. (1999) Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells. Blood, 94, 3986-3996.
9. Lomas, C., McColl, K. & Tippett, P. (1993) Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti-D. Transfusion Medicine, 3, 67-69.
10. Scott, M. (2001) Monoclonal anti-D for immunoprophylaxis. Vox Sanguinis, 81, 213-218.
11. Scott, M. (2002) Section 1A: Rh serology Coordinator's report. Transfusion Clinique et Biologique, 9, 23-29.
12. Thorpe, S.J. & Heath, A.B. (1995) Development and evaluation of a competitive radioimmunoassay using monoclonal antibodies against Rh D for determining anti-D potency of clinical grade immunoglobulin preparations. Transfusion Medicine, 5, 97-103.
13. Thorpe, S.J., Sands, D., Rautmann, G. & Schäffner, G. (2002) International collaborative study to evaluate methods for quantification of anti-D in immunoglobulin preparations. Vox Sanguinis, 83, 42-50.
14. Thorpe, S.J., Turner, C.E., Heath, A. & Sands, D. (2000) A competitive enzyme-linked immunoassay using erythrocytes fixed to microtitre plates for anti-D quantitation in immunoglobulin products. Vox Sanguinis, 79, 100-107.